Skip to main content

Table 1 Clusterin expression pattern in the primary and recurrent ovarian cancers

From: Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

Case (patient's age)

Chemo-senitivity

primary tumor

Persistent/recurrent t.

histology

FIGO stage

  

CLU intensity

CLU intensity

  

1 (57)

responsive

++

+

serous

IIIc

2 (48)

responsive

++

+

serous

IIIc

3 (48)

resistant

+

++

serous

IV

4 (53)

resistant

+

+++

serous

IV

5 (59)

resistant

+

+++

serous

IV

6 (52)

resistant

++

+++

serous

IIIc

7 (51)

resistant

N

++

serous

IV

8 (55)

resistant

+++

+++

serous

IIIC

  1. N denotes negative staining, (+) denote weak staining (++) denote moderate staining, while (+++) denotes strong staining.